BIOCRYST PHARMACEUTICALS INC 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 15, 2012
Insider Transaction Report
Form 4
SANDERS CHARLES A
Director
Transactions
- Purchase
Common Stock
2012-03-13$5.21/sh+2,000$10,430→ 7,000 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.24. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.